日韩久久精品视频在线观看,國產色產綜合色產在線觀看視頻,国产中国免费视频观看

規格

規格	1 slide (4 wells) 、 4 Sample Kit 、 8 Sample Kit 、 16 Sample Kit 、 1 slide (4 wells) 、 1 slide (4 wells) 、 4 Sample Kit 、 8 Sample Kit 、 16 Sample Kit
樣本類型	Plasma,Serum,Ascites,Hybridoma cell culture medium,Purified antibodies,Purified protein,DNA Aptamers,Other fluids
靶標基因	CTLA4
檢測方法	Fluorescence Laser Scanner
定量與否	Semi-Quantitative
運輸條件	Blue ice
載體	Glass Slide
適用種屬	Human

詳細描述

_x000D_

Peptide Information

_x000D_

Number of Peptides:_x000D_

177

_x000D_

Peptide Length:_x000D_

12-mer

_x000D_

Peptide Offset:_x000D_

1-mer

_x000D_

Peptide Purity:_x000D_

HPLC grade, >95% purity

_x000D_

Array Printing Replicate:_x000D_

Triplicate

_x000D_

Peptide Sequence

_x000D_

_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_

1. KAMHVAQPAVVL	46. VTEVCAATYMMG	91. LYICKVELMYPP	136. SSGLFFYSFLLT
2. AMHVAQPAVVLA	47. TEVCAATYMMGN	92. YICKVELMYPPP	137. SGLFFYSFLLTA
3. MHVAQPAVVLAS	48. EVCAATYMMGNE	93. ICKVELMYPPPY	138. GLFFYSFLLTAV
4. HVAQPAVVLASS	49. VCAATYMMGNEL	94. CKVELMYPPPYY	139. LFFYSFLLTAVS
5. VAQPAVVLASSR	50. CAATYMMGNELT	95. KVELMYPPPYYL	140. FFYSFLLTAVSL
6. AQPAVVLASSRG	51. AATYMMGNELTF	96. VELMYPPPYYLG	141. FYSFLLTAVSLS
7. QPAVVLASSRGI	52. ATYMMGNELTFL	97. ELMYPPPYYLGI	142. YSFLLTAVSLSK
8. PAVVLASSRGIA	53. TYMMGNELTFLD	98. LMYPPPYYLGIG	143. SFLLTAVSLSKM
9. AVVLASSRGIAS	54. YMMGNELTFLDD	99. MYPPPYYLGIGN	144. FLLTAVSLSKML
10. VVLASSRGIASF	55. MMGNELTFLDDS	100. YPPPYYLGIGNG	145. LLTAVSLSKMLK
11. VLASSRGIASFV	56. MGNELTFLDDSI	101. PPPYYLGIGNGT	146. LTAVSLSKMLKK
12. LASSRGIASFVC	57. GNELTFLDDSIC	102. PPYYLGIGNGTQ	147. TAVSLSKMLKKR
13. ASSRGIASFVCE	58. NELTFLDDSICT	103. PYYLGIGNGTQI	148. AVSLSKMLKKRS
14. SSRGIASFVCEY	59. ELTFLDDSICTG	104. YYLGIGNGTQIY	149. VSLSKMLKKRSP
15. SRGIASFVCEYA	60. LTFLDDSICTGT	105. YLGIGNGTQIYV	150. SLSKMLKKRSPL
16. RGIASFVCEYAS	61. TFLDDSICTGTS	106. LGIGNGTQIYVI	151. LSKMLKKRSPLT
17. GIASFVCEYASP	62. FLDDSICTGTSS	107. GIGNGTQIYVID	152. SKMLKKRSPLTT
18. IASFVCEYASPG	63. LDDSICTGTSSG	108. IGNGTQIYVIDP	153. KMLKKRSPLTTG
19. ASFVCEYASPGK	64. DDSICTGTSSGN	109. GNGTQIYVIDPE	154. MLKKRSPLTTGV
20. SFVCEYASPGKA	65. DSICTGTSSGNQ	110. NGTQIYVIDPEP	155. LKKRSPLTTGVY
21. FVCEYASPGKAT	66. SICTGTSSGNQV	111. GTQIYVIDPEPC	156. KKRSPLTTGVYV
22. VCEYASPGKATE	67. ICTGTSSGNQVN	112. TQIYVIDPEPCP	157. KRSPLTTGVYVK
23. CEYASPGKATEV	68. CTGTSSGNQVNL	113. QIYVIDPEPCPD	158. RSPLTTGVYVKM
24. EYASPGKATEVR	69. TGTSSGNQVNLT	114. IYVIDPEPCPDS	159. SPLTTGVYVKMP
25. YASPGKATEVRV	70. GTSSGNQVNLTI	115. YVIDPEPCPDSD	160. PLTTGVYVKMPP
26. ASPGKATEVRVT	71. TSSGNQVNLTIQ	116. VIDPEPCPDSDF	161. LTTGVYVKMPPT
27. SPGKATEVRVTV	72. SSGNQVNLTIQG	117. IDPEPCPDSDFL	162. TTGVYVKMPPTE
28. PGKATEVRVTVL	73. SGNQVNLTIQGL	118. DPEPCPDSDFLL	163. TGVYVKMPPTEP
29. GKATEVRVTVLR	74. GNQVNLTIQGLR	119. PEPCPDSDFLLW	164. GVYVKMPPTEPE
30. KATEVRVTVLRQ	75. NQVNLTIQGLRA	120. EPCPDSDFLLWI	165. VYVKMPPTEPEC
31. ATEVRVTVLRQA	76. QVNLTIQGLRAM	121. PCPDSDFLLWIL	166. YVKMPPTEPECE
32. TEVRVTVLRQAD	77. VNLTIQGLRAMD	122. CPDSDFLLWILA	167. VKMPPTEPECEK
33. EVRVTVLRQADS	78. NLTIQGLRAMDT	123. PDSDFLLWILAA	168. KMPPTEPECEKQ
34. VRVTVLRQADSQ	79. LTIQGLRAMDTG	124. DSDFLLWILAAV	169. MPPTEPECEKQF
35. RVTVLRQADSQV	80. TIQGLRAMDTGL	125. SDFLLWILAAVS	170. PPTEPECEKQFQ
36. VTVLRQADSQVT	81. IQGLRAMDTGLY	126. DFLLWILAAVSS	171. PTEPECEKQFQP
37. TVLRQADSQVTE	82. QGLRAMDTGLYI	127. FLLWILAAVSSG	172. TEPECEKQFQPY
38. VLRQADSQVTEV	83. GLRAMDTGLYIC	128. LLWILAAVSSGL	173. EPECEKQFQPYF
39. LRQADSQVTEVC	84. LRAMDTGLYICK	129. LWILAAVSSGLF	174. PECEKQFQPYFI
40. RQADSQVTEVCA	85. RAMDTGLYICKV	130. WILAAVSSGLFF	175. ECEKQFQPYFIP
41. QADSQVTEVCAA	86. AMDTGLYICKVE	131. ILAAVSSGLFFY	176. CEKQFQPYFIPI
42. ADSQVTEVCAAT	87. MDTGLYICKVEL	132. LAAVSSGLFFYS	177. EKQFQPYFIPIN
43. DSQVTEVCAATY	88. DTGLYICKVELM	133. AAVSSGLFFYSF
44. SQVTEVCAATYM	89. TGLYICKVELMY	134. AVSSGLFFYSFL
45. QVTEVCAATYMM	90. GLYICKVELMYP	135. VSSGLFFYSFLL

_x000D_

Application Notes

_x000D_

Identify high antigenicity epitopes for antibody production & vaccine development
Locate (auto)antigen epitopes of (auto)antibodies
Define the best antibody clone against the protein-of-interest
Perform epitope mutant analysis
Map B cell epitopes

_x000D_

Service Features

_x000D_

Small serum sample volume required (2 μl)
High density (simultaneously analyze hundreds of overlapping peptides)
High sensitivity
Large dynamic range
Suitable for high-throughput assays
High efficiency and accuracy
Affordable, quick and simple to use

_x000D_

Kit Components

_x000D_

RayBio^??human CLTA-4 protein peptide array
Blocking Buffer
Wash Buffer I
Wash Buffer II
Biotin-conjugated secondary antibody
Cy3 equivalent dye conjugated streptavidin
Array accessories (including slide incubation chamber assembly, gasket, adhesive plastic strips, etc.)

_x000D_

Other Materials Required

_x000D_

Distilled water
Small plastic boxes or containers
Orbital shaker or oscillating rocker
Pipettors, pipette tips and other common lab consumables
Aluminum foil
Laser fluorescence scanner

_x000D_

View Compatible Laser Scanners

_x000D_

Don't have a compatible scanner? RayBiotech now offers FREE scanning service for all RayBio glass slide antibody arrays! Learn More

_x000D_

Storage/Stability

_x000D_

Upon receipt, all kit components should be stored at -20 °C to -80 °C until ready to use. Stored properly, the kit will retain complete activity for up to 6 months.

相關產品

Anti-Gus

Anti-Xa21

Anti-HPT

Anti-CP4-EPSPS

文件

文獻(0)

View all

訂購信息

可聯系當地經銷商進行訂購。

聯系經銷商

幫助